Unusual total active option classes on open include: Gain Therapeutics (GANX), Arteris (AIP), Northern Dynasty (NAK), Cedar Fair (FUN), Fly Leasing Ltd (FLY), SES AI Corp (SES), UiPath (PATH), Archer Aviation (ACHR), Pan American Silver (PAAS), and NextDecade Corp (NEXT).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GANX:
- Gain Therapeutics presents initial data from Phase 1b study of GT-02287
- Gain Therapeutics begins GT-02287 Phase 1b extension study in Parkinson’s
- Positive Buy Rating for Gain Therapeutics Driven by Promising Clinical Trial Developments and Strong Financial Outlook
- Promising Developments and Regulatory Milestones Bolster Buy Rating for Gain Therapeutics
- Gain Therapeutics receives Australian approval of Phase 1b dosing extension